Type 2 diabetes: open trials in Finland

11 open trials have a site in Finland. Registry data; only the trial team decides who can take part.

NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
CRST Helsinki Oy, Helsinki · Suomen Terveystalo Oy, Helsinki · HUS-Yhtymae, Helsinki · Studycor Oy, Jyväskylä · Health Step Finland Oy, Kuopio · Pirkanmaan hyvinvointialue, Tampere · Suomen Terveystalo Oy, Tampere · Suomen Terveystalo Oy, Turku · Turku University Hospital, Turku
Registry updated 2026-10-28
NCT06072326
dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation
Trial Treatment · Phase 2 · University Medical Center Groningen
HUS Helsinki University Hospital, Helsinki · Turku University Hospital, Turku
Registry updated 2026-10-20
NCT06486012
Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients
Trial Treatment · Wellbeing Services County of Pirkanmaa
Wellbeing Services of County Pirkanmaa, Tampere
Registry updated 2026-10-16
NCT05633810
COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
Trial Treatment · Phase 3 · Montreal Heart Institute
HUS-Yhtymae, Helsinki
Registry updated 2026-10-06
NCT07820800
NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)
Trial Treatment · University of Eastern Finland
Wellbeing Services County of South Savo (Eloisa) (provide social and healthcare services and emergency services in the Enonkoski, Hirvensalmi, Juva, Kangasniemi, Mikkeli, Mäntyharju, Pieksämäki, Puumala, Rantasalmi, Savonlinna ja Sulkava), Savonlinna
Registry updated 2026-10-06
NCT05663515
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Research · AstraZeneca
Helsinki
Registry updated 2026-09-24
NCT07322757
Outcomes-Based Health Program for Type 2 Diabetes
Trial Treatment · Kuopio University Hospital
Wellbeing services county of North Savo, Nursing and Physician Services, Kuopio
Registry updated 2026-01-07
NCT06923735
Nutrition Apps in Occupational Healthcare (Pilot Study of the FOODNUTRI Project)
Trial Treatment · University of Eastern Finland
University Of Eastern Finland, Kuopio
Registry updated 2025-04-17
NCT04442334
The European NAFLD Registry
Research · Newcastle University
Helsinki University Hospital, Helsinki
Registry updated 2023-01-06
NCT04619836
Cost-effectiveness of the Care Pathways
Research · Tampere University Hospital
Tampere University Hospital, Tampere
Registry updated 2021-10-19
NCT03156478
STOP DIABETES - Knowledge-based Solutions
Trial Treatment · University of Eastern Finland
University Of Eastern Finland, Kuopio
Registry updated 2017-05-17

All Type 2 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error